Biomaterials Market Innovations: Emerging Technologies Transforming Applications

 The global biomaterials market was valued at USD 178.0 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 15.6% from 2024 to 2030. This growth is primarily driven by the increasing prevalence of musculoskeletal and chronic skeletal conditions, which is expected to boost the demand for biomaterial-based implants. Chronic conditions such as osteoarthritis and degenerative diseases are particularly fueling the need for advanced biomaterials, as joint replacements and augmentations become essential for patients suffering from mobility issues and pain due to these conditions.

Metallic biomaterials, known for their durability and long-lasting properties, are well-suited for implants that integrate with the body, restoring function and improving the quality of life for patients. Advances in biomaterials technology continually enhance these materials, focusing on improving biocompatibility, corrosion resistance, and the ability to integrate seamlessly with biological systems. These innovations result in implants that not only withstand the body's natural biomechanics but also promote healing and reduce the risk of complications after surgery.

Gather more insights about the market drivers, restrains and growth of the Global Biomaterials Market

In addition to technological advancements, the aging global population is a significant factor driving the demand for biomaterials. As people age, the incidence of chronic conditions and age-related injuries increases, leading to a greater need for durable medical interventions. Biomaterials provide solutions that meet the healthcare needs of an aging demographic, addressing these challenges with effective and durable options.

The demand for novel biomaterials has also been rising in recent years due to their expanding applications in tissue replacement and repair, including bones, teeth, and other organs. This growing adoption is largely attributed to technological developments, particularly in nanotechnology, which allows treatments to be administered at the molecular level. Advanced biomaterials are also emerging as a solution to challenges faced by traditional autologous or allograft treatments, such as donor shortages, immune rejection, and mismatches in size or modality.

Polymeric artificial constructs, which mimic the structural and functional properties of the extracellular matrix, are being used to promote cell growth. In addition, new polymeric materials are being introduced to complement existing implant solutions and improve their effectiveness. For example, in March 2022, Evonik launched its osteoconductive VESTAKEEP iC4800 3DF PEEK filament, a 3D-printable biomaterial that enhances the fusion between implants and bone. Such innovations are expected to further drive the growth of the biomaterials market.

Product Insights

The metallic biomaterials segment accounted for the largest share of the market in 2023, contributing over 40% of the total revenue. This dominance is due to the unique combination of mechanical properties, biocompatibility, and corrosion resistance that metals offer. Metals are widely used in the production of load-bearing implants, particularly in orthopedic surgeries. These implants include wires, screws, fracture fixation plates, and prostheses for joints such as hips, knees, shoulders, and ankles. The established track record of metallic biomaterials in medical applications, along with ongoing research aimed at improving their functionality, has reinforced their widespread use in various medical devices and implants.

The natural biomaterials segment is expected to experience strong growth during the forecast period, driven by the advantages of biodegradability, biocompatibility, and remodeling when compared to synthetic biomaterials. Natural biomaterials are increasingly being used to restore or replace damaged organs and tissues. For example, biosensors, which detect biological elements such as biomolecules, tissues, enzymes, and organelles, are an important application of natural biomaterials. When implanted, natural biomaterials promote cell adhesion, proliferation, and differentiation, factors that are expected to drive the growth of this segment in the coming years.

Application Insights

In 2023, the orthopedic segment led the market in terms of revenue. The increasing adoption of metallic biomaterials in orthopedic applications, due to their high load-bearing capacity, is a key factor driving this growth. Additionally, market players are continuously working to introduce advanced orthopedic implants. For instance, in November 2019, DiFusion Inc. received FDA approval for its Xiphos-ZF spinal interbody device, which utilizes an innovative biomaterial called Zfuze—a combination of poly-ether-ether-ketone (PEEK) and titanium. This biomaterial has demonstrated a significant reduction in cytokine markers linked to inflammation and fibrous tissue formation, making it a breakthrough in orthopedic treatments.

The plastic surgery segment is projected to register the fastest growth rate over the forecast period, driven by increasing demand for cosmetic procedures and reconstructive surgeries following accidents or diseases. Advances in biomaterial technology have led to more durable and customizable implants, which are further driving this segment’s growth. Moreover, the growing aging population, along with a rising interest in maintaining a youthful appearance, is expected to fuel the demand for plastic surgery, positively influencing the overall market growth.

Order a free sample PDF of the Biomaterials Market Intelligence Study, published by Grand View Research.